FAP low-expressing CAFs reduce the promoting effect of FAP high-expressing CAFs on tumor through specific genes such as TCF21 (51); CAFs not only show differences in ovarian cancer but also in other cancers. This evidence concerns the gene FAP and ovarian cancer.